Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.65 USD | -0.13% | +2.38% | +20.81% |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.81% | 5.69B | |
+9.89% | 115B | |
+11.90% | 106B | |
-2.59% | 21.96B | |
-12.36% | 21.87B | |
-5.29% | 19.21B | |
-4.11% | 18.08B | |
-38.57% | 17.71B | |
+7.24% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024